However, further research on the association of irisin with circulating EMPs and EPCs in preterm-born individuals is required, including in vitro and experimental models, to better clarify and improve knowledge regarding the potential pathways underlying the link between irisin and the early stages of prematurity-related endothelial dysfunction. This evidence concerns the gene FNDC5 and endothelial dysfunction.